Literature DB >> 22710122

Azole preexposure affects the Aspergillus fumigatus population in patients.

Alexandre Alanio1, Odile Cabaret, Emilie Sitterlé, Jean-Marc Costa, Sylvain Brisse, Catherine Cordonnier, Stéphane Bretagne.   

Abstract

The relationship between the azole preexposure of 86 patients and the genotype, azole susceptibility, and cyp51A polymorphisms of 110 corresponding Aspergillus fumigatus isolates was explored. Isolates carrying serial polymorphisms (F46Y and M172V with or without N248T with or without D255E with or without E427K) had higher itraconazole MICs (P = 0.04), although <2 μg/ml using the EUCAST methodology, were associated with two genetic clusters (P < 0.001) and with voriconazole preexposure of patients (P = 0.016). Voriconazole preexposure influences the distribution of A. fumigatus isolates with selection of isolates carrying cyp51A polymorphisms and higher itraconazole MICs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710122      PMCID: PMC3421863          DOI: 10.1128/AAC.05990-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  TM4: a free, open-source system for microarray data management and analysis.

Authors:  A I Saeed; V Sharov; J White; J Li; W Liang; N Bhagabati; J Braisted; M Klapa; T Currier; M Thiagarajan; A Sturn; M Snuffin; A Rezantsev; D Popov; A Ryltsov; E Kostukovich; I Borisovsky; Z Liu; A Vinsavich; V Trush; J Quackenbush
Journal:  Biotechniques       Date:  2003-02       Impact factor: 1.993

Review 2.  Small change: keeping pace with microevolution.

Authors:  Edward J Feil
Journal:  Nat Rev Microbiol       Date:  2004-06       Impact factor: 60.633

3.  Microsatellite based typing of Aspergillus fumigatus: strengths, pitfalls and solutions.

Authors:  Hanneke A de Valk; Jacques F G M Meis; Corné H W Klaassen
Journal:  J Microbiol Methods       Date:  2007-01-31       Impact factor: 2.363

4.  Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

Authors:  Oliver A Cornely; Johan Maertens; Drew J Winston; John Perfect; Andrew J Ullmann; Thomas J Walsh; David Helfgott; Jerzy Holowiecki; Dick Stockelberg; Yeow-Tee Goh; Mario Petrini; Cathy Hardalo; Ramachandran Suresh; David Angulo-Gonzalez
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

5.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Authors:  Andrew J Ullmann; Jeffrey H Lipton; David H Vesole; Pranatharthi Chandrasekar; Amelia Langston; Stefano R Tarantolo; Hildegard Greinix; Wellington Morais de Azevedo; Vijay Reddy; Navdeep Boparai; Lisa Pedicone; Hernando Patino; Simon Durrant
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

6.  Microsatellite typing of Aspergillus fumigatus isolates recovered from deep organ samples of patients with invasive aspergillosis.

Authors:  Lies M E Vanhee; Francoise Symoens; Hans J Nelis; Tom Coenye
Journal:  Diagn Microbiol Infect Dis       Date:  2008-05-22       Impact factor: 2.803

7.  Usefulness of genotyping with microsatellite markers to investigate hospital-acquired invasive aspergillosis.

Authors:  E Bart-Delabesse; C Cordonnier; S Bretagne
Journal:  J Hosp Infect       Date:  1999-08       Impact factor: 3.926

8.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

9.  Microsatellite markers for typing Aspergillus fumigatus isolates.

Authors:  E Bart-Delabesse; J F Humbert; E Delabesse; S Bretagne
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Mutations in the CYP51 gene correlated with changes in sensitivity to sterol 14 alpha-demethylation inhibitors in field isolates of Mycosphaerella graminicola.

Authors:  Pierre Leroux; Catherine Albertini; Angélique Gautier; Michel Gredt; Anne-Sophie Walker
Journal:  Pest Manag Sci       Date:  2007-07       Impact factor: 4.845

View more
  14 in total

1.  Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.

Authors:  Laís Pontes; Caio Augusto Gualtieri Beraquet; Teppei Arai; Guilherme Leite Pigolli; Luzia Lyra; Akira Watanabe; Maria Luiza Moretti; Angélica Zaninelli Schreiber
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 2.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  A Simple Method To Detect Point Mutations in Aspergillus fumigatus cyp51A Gene Using a Surveyor Nuclease Assay.

Authors:  Teppei Arai; Hidetaka Majima; Akira Watanabe; Katsuhiko Kamei
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Nationwide Surveillance of Azole Resistance in Aspergillus Diseases.

Authors:  Edith Vermeulen; Johan Maertens; Annelies De Bel; Eric Nulens; Jerina Boelens; Ignace Surmont; Anna Mertens; An Boel; Katrien Lagrou
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

Review 5.  Triazole Resistance in Aspergillus Species: An Emerging Problem.

Authors:  Rocio Garcia-Rubio; Manuel Cuenca-Estrella; Emilia Mellado
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 6.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

7.  An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus.

Authors:  Cau D Pham; Shawn R Lockhart
Journal:  Curr Fungal Infect Rep       Date:  2012-12-16

8.  Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases.

Authors:  Yanan Zhao; Christen R Stensvold; David S Perlin; Maiken C Arendrup
Journal:  J Antimicrob Chemother       Date:  2013-03-05       Impact factor: 5.790

9.  Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.

Authors:  Rocio Garcia-Rubio; Laura Alcazar-Fuoli; Maria Candida Monteiro; Sara Monzon; Isabel Cuesta; Teresa Pelaez; Emilia Mellado
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

10.  In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.

Authors:  Seyedmojtaba Seyedmousavi; Joseph Meletiadis; Willem J G Melchers; Antonius J M M Rijs; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.